Cargando…
Role of Canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetes
BACKGROUND: Endothelial progenitor cells (EPCs) has been shown to be dysfunctional in both type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD) leading to poor regeneration of endothelium and renal perfusion. EPCs have been shown to be a robust cardiovascular disease (CVD) risk indicator...
Autores principales: | Nandula, Seshagiri Rao, Kundu, Nabanita, Awal, Hassan B., Brichacek, Beda, Fakhri, Mona, Aimalla, Nikhila, Elzarki, Adrian, Amdur, Richard L., Sen, Sabyasachi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881606/ https://www.ncbi.nlm.nih.gov/pubmed/33581737 http://dx.doi.org/10.1186/s12933-021-01235-4 |
Ejemplares similares
-
Linagliptin, when compared to placebo, improves CD34+ve endothelial progenitor cells in type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin: a randomized controlled trial
por: Awal, Hassan B., et al.
Publicado: (2020) -
Cardiovascular disease (CVD) risk assessment of HIV medication regimens using hematopoietic CD34+ progenitor cells
por: Elzarki, Adrian Farid, et al.
Publicado: (2022) -
Transplantation of Apoptosis‐Resistant Endothelial Progenitor Cells Improves Renal Function in Diabetic Kidney Disease
por: Kundu, Nabanita, et al.
Publicado: (2021) -
Comparison Between Linagliptin and Canagliflozin Effect on Inflammatory Markers, CD34+ Cell Gene Expression and Urine Exosomes in Type 2 Diabetes Subjects
por: Nandula, Seshagiri R, et al.
Publicado: (2021) -
SUN-578 Role of Linagliptin on CD34+ Endothelial Progenitor Cells and Arterial Stiffness in Renal Function Impaired Type 2 Diabetes Subjects
por: Awal, Hassan, et al.
Publicado: (2020)